Cargando…

U-Omp19 from Brucella abortus increases dmLT immunogenicity and improves protection against Escherichia coli heat-labile toxin (LT) oral challenge

Acute diarrhea disease caused by bacterial infections is a major global health problem. Enterotoxigenic Escherichia coli (ETEC) is one of the top causes of diarrhea-associated morbidity and mortality in young children and travelers to low-income countries. There are currently no licensed vaccines fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coria, Lorena M., Martinez, Franco L., Bruno, Laura A., Pasquevich, Karina A., Cassataro, Juliana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327514/ https://www.ncbi.nlm.nih.gov/pubmed/32536545 http://dx.doi.org/10.1016/j.vaccine.2020.05.039

Ejemplares similares

The Mucosal Vaccine Adjuvant LT(R192G/L211A) or dmLT
por: Clements, John D., et al.
Publicado: (2018)

Development of a candidate stabilizing formulation for bulk storage of a double mutant heat labile toxin (dmLT) protein based adjuvant
por: Toprani, Vishal M., et al.
Publicado: (2017)

Omp19 Enables Brucella abortus to Evade the Antimicrobial Activity From Host's Proteolytic Defense System
por: Pasquevich, Karina A., et al.
Publicado: (2019)

U-Omp19 from Brucella abortus Is a Useful Adjuvant for Vaccine Formulations against Salmonella Infection in Mice
por: Risso, Gabriela S., et al.
Publicado: (2017)

Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized study
por: Erdem, Rahsan, et al.
Publicado: (2023)

Identifying a stable bulk dmLT adjuvant formulation at a clinically relevant concentration
por: Estrada, Marcus R., et al.
Publicado: (2023)

The LT1 and LT2 variants of the enterotoxigenic Escherichia coli (ETEC) heat-labile toxin (LT) are associated with major ETEC lineages
por: Joffré, Enrique, et al.
Publicado: (2016)

dmLT Adjuvant Enhances Cytokine Responses to T Cell Stimuli, Whole Cell Vaccine Antigens and Lipopolysaccharide in Both Adults and Infants
por: Akhtar, Marjahan, et al.
Publicado: (2021)

Route and antigen shape immunity to dmLT-adjuvanted vaccines to a greater extent than biochemical stress or formulation excipients
por: Stone, Addison E., et al.
Publicado: (2023)

The adjuvants dmLT and mmCT enhance humoral immune responses to a pneumococcal conjugate vaccine after both parenteral or mucosal immunization of neonatal mice
por: Molina Estupiñan, Jenny Lorena, et al.
Publicado: (2023)

Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge
por: Harro, Clayton, et al.
Publicado: (2019)

LTA1 and dmLT enterotoxin-based proteins activate antigen-presenting cells independent of PKA and despite distinct cell entry mechanisms
por: Valli, Eduardo, et al.
Publicado: (2020)

Fentanyl conjugate vaccine by injected or mucosal delivery with dmLT or LTA1 adjuvants implicates IgA in protection from drug challenge
por: Stone, Addison E., et al.
Publicado: (2021)

Reply to LT Cacau and DM Marchioni
por: Stubbendorff, Anna, et al.
Publicado: (2022)

An Oral Vaccine Based on U-Omp19 Induces Protection against B. abortus Mucosal Challenge by Inducing an Adaptive IL-17 Immune Response in Mice
por: Pasquevich, Karina A., et al.
Publicado: (2011)

Stability Studies of the Vaccine Adjuvant U-Omp19
por: Darriba, M. Laura, et al.
Publicado: (2021)

Evaluating the A-Subunit of the Heat-Labile Toxin (LT) As an Immunogen and a Protective Antigen Against Enterotoxigenic Escherichia coli (ETEC)
por: Norton, Elizabeth B., et al.
Publicado: (2015)

Unlipidated Outer Membrane Protein Omp16 (U-Omp16) from Brucella spp. as Nasal Adjuvant Induces a Th1 Immune Response and Modulates the Th2 Allergic Response to Cow’s Milk Proteins
por: Ibañez, Andrés E., et al.
Publicado: (2013)

Adjuvant effect of enterotoxigenic Escherichia coli (ETEC) double-mutant heat-labile toxin (dmLT) on systemic immunogenicity induced by the CFA/I/II/IV MEFA ETEC vaccine: Dose-related enhancement of antibody responses to seven ETEC adhesins (CFA/I, CS1-CS6)
por: Seo, Hyesuk, et al.
Publicado: (2019)

Correction: Evaluating the A-Subunit of the Heat-Labile Toxin (LT) As an Immunogen and a Protective Antigen Against Enterotoxigenic Escherichia coli (ETEC)
Publicado: (2015)

Whole-Genome Shotgun Sequences of Salmonella enterica Serovar Typhimurium Lilleengen Type Strains LT1, LT18, LT19, LT20, LT21, and LT22
por: Kazmierczak, Robert A., et al.
Publicado: (2017)

Expression of proteins Heat-Labile (Lt-1) and Heat-Stable (STa) Escherichia coli expression of proteins Heat-Labile (Lt-1) and Heat-Stable (STa) Escherichia coli
por: Cavalcante, Alessandra, et al.
Publicado: (2014)

Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus serotypes in a randomized placebo-controlled trial
por: Crothers, Jessica W., et al.
Publicado: (2022)

Characterization of the ganglioside recognition profile of Escherichia coli heat-labile enterotoxin LT-IIc
por: Zalem, Dani, et al.
Publicado: (2021)

Protective effects of recombinant Brucella abortus Omp28 against infection with a virulent strain of Brucella abortus 544 in mice
por: Lim, Jeong Ju, et al.
Publicado: (2012)

Alkaline pH Is a Signal for Optimal Production and Secretion of the Heat Labile Toxin, LT in Enterotoxigenic Escherichia Coli (ETEC)
por: Gonzales, Lucia, et al.
Publicado: (2013)

The Divergent CD8(+) T Cell Adjuvant Properties of LT-IIb and LT-IIc, Two Type II Heat-Labile Enterotoxins, Are Conferred by Their Ganglioside-Binding B Subunits
por: Hu, John C., et al.
Publicado: (2015)

Intradermal Administration of the Type II Heat-Labile Enterotoxins LT-IIb and LT-IIc of Enterotoxigenic Escherichia coli Enhances Humoral and CD8(+) T Cell Immunity to a Co-Administered Antigen
por: Hu, John C., et al.
Publicado: (2014)

Lt.-Col. Maynard
Publicado: (1921)

A disordered region retains the full protease inhibitor activity and the capacity to induce CD8(+) T cells in vivo of the oral vaccine adjuvant U-Omp19
por: Laura Darriba, M., et al.
Publicado: (2022)

Designing a combined liothyronine (LT3), L- thyroxine (LT4) trial in symptomatic hypothyroid subjects on LT4 - the importance of patient selection, choice of LT3 and trial design
por: Premawardhana, Lakdasa D., et al.
Publicado: (2023)

Corrigendum to “Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus serotypes in a randomized active-controlled trial” [Vaccine 40(19) (2022) 2705–2713]
por: Crothers, Jessica W., et al.
Publicado: (2022)

Net widens for funding of <i>arXiv</i>
Publicado: (2010)

Ligamentum Teres (LT) Rupture: Safety And Efficacy Of Allograft And Synthetic Ligament In LT Reconstruction
por: Bajwa, Ali S., et al.
Publicado: (2016)

Both LTA and LTB Subunits Are Equally Important to Heat-Labile Enterotoxin (LT)-Enhanced Bacterial Adherence
por: Duan, Qiangde, et al.
Publicado: (2023)

Protection of BALB/c mice against pathogenic Brucella abortus and Brucella melitensis by vaccination with recombinant Omp16
por: Alizadeh, Hamed, et al.
Publicado: (2019)

Lt.-Col. Robert Pringle
Publicado: (1899)

Reply letter to Leong LT
por: Girometti, Rossano, et al.
Publicado: (2020)

Lt. Martin F. Nolan
Publicado: (1918)

Brucella abortus antigen omp25 vaccines: Development and targeting based on Lactococcus lactis
por: Gouran, Somaye Tirbakhsh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g3a5ofbgojpiqhhhr2kbm8bo5r